2021
DOI: 10.1101/2021.05.08.443244
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

The K18-hACE2 Transgenic Mouse Model Recapitulates Non-Severe and Severe COVID-19 in Response to Infectious Dose of SARS-CoV-2 Virus

Abstract: A comprehensive analysis and characterization of a SARS-CoV-2 infection model that mimics non-severe and severe COVID-19 in humans is warranted for understating the virus and developing preventive and therapeutic agents. Here, we characterized the K18-hACE2 mouse model expressing human (h)ACE2 in mice, controlled by the human keratin 18 (K18) promoter, in epithelia, including airway epithelial cells where SARS-CoV-2 infections typically start. We found that intranasal inoculation with higher viral doses (2x103… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 31 publications
0
6
0
Order By: Relevance
“…In contrast, mice infected with Alpha exhibited low RNA levels at day 2 and a 2-fold increase at day 6, suggesting an increase in viral replication in the brain over time (Fig 2C). These observations suggest that Delta at a challenge dose of 10 3 PFU replicates efficiently in the airway in a manner similar to Alpha but Delta appears to have lower brain localization previously observed in K18-hACE2-mice [41,[44][45][46]. Viral RNA burden of disease-associated tissues was quantified using nucleocapsid qPCR.…”
Section: Plos Onementioning
confidence: 78%
See 1 more Smart Citation
“…In contrast, mice infected with Alpha exhibited low RNA levels at day 2 and a 2-fold increase at day 6, suggesting an increase in viral replication in the brain over time (Fig 2C). These observations suggest that Delta at a challenge dose of 10 3 PFU replicates efficiently in the airway in a manner similar to Alpha but Delta appears to have lower brain localization previously observed in K18-hACE2-mice [41,[44][45][46]. Viral RNA burden of disease-associated tissues was quantified using nucleocapsid qPCR.…”
Section: Plos Onementioning
confidence: 78%
“…We observed that 10 3 PFU challenge with Delta variant does not cause the dramatic weight loss and hypothermia reported in models of Alpha and Beta challenge [ 17 ]. One well known caveat of the K18-hACE2-mouse model is the fact that WA-1, Alpha and Beta strains enter the brain [ 44 , 46 , 58 64 ]. However, it appears that the Delta variant remains more localized in the lungs of challenged mice ( Fig 3 ).…”
Section: Discussionmentioning
confidence: 99%
“…The value of R changes with the type of activity but is currently uncertain. Also, the value of I may change independently since the dose may change with the severity of the COVID-19 disease [54,55]; age has also been suggested to influence disease severity [56,57]. Moreover, it has been suggested that some SARS-CoV-2 variants, such as the Delta variant, are more infectious corresponding to higher values of I [58].…”
Section: Modelling Frameworkmentioning
confidence: 99%
“…To evaluate the potential effect of FXa in vivo, we used humanized K18-hACE2 mice as an infection model of SARS-CoV-2 23,24 .…”
Section: Fxa Cleavage Reduces the Binding Between S Protein And Ace2mentioning
confidence: 99%